B Meyer

978 total citations
32 papers, 759 citations indexed

About

B Meyer is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Hematology. According to data from OpenAlex, B Meyer has authored 32 papers receiving a total of 759 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Immunology and 8 papers in Hematology. Recurrent topics in B Meyer's work include Multiple Myeloma Research and Treatments (7 papers), Immune Cell Function and Interaction (5 papers) and Immunotherapy and Immune Responses (5 papers). B Meyer is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Immune Cell Function and Interaction (5 papers) and Immunotherapy and Immune Responses (5 papers). B Meyer collaborates with scholars based in Austria, United Kingdom and Germany. B Meyer's co-authors include Angus Dalgleish, Christine Galustian, Jake Y. Henry, Marie‐Christine Labarthe, J. Blake Bartlett, Peter Schäfer, David Stirling, Roger Chen, Keith Dredge and George W. Muller and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and The Journal of Urology.

In The Last Decade

B Meyer

30 papers receiving 740 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B Meyer Austria 12 310 303 301 258 81 32 759
Toru Masaoka Japan 14 189 0.6× 240 0.8× 211 0.7× 140 0.5× 159 2.0× 54 745
S Okamura Japan 17 289 0.9× 167 0.6× 180 0.6× 144 0.6× 43 0.5× 45 683
Issaka Yougbaré Canada 13 177 0.6× 402 1.3× 54 0.2× 236 0.9× 41 0.5× 23 847
Masanori Higuchi Japan 13 396 1.3× 215 0.7× 89 0.3× 101 0.4× 30 0.4× 25 750
Mayuko Tamura Japan 10 261 0.8× 134 0.4× 226 0.8× 140 0.5× 52 0.6× 26 639
Marie‐Lorraine Chrétien France 15 150 0.5× 301 1.0× 223 0.7× 283 1.1× 130 1.6× 31 699
Diana Chan United States 8 243 0.8× 60 0.2× 117 0.4× 143 0.6× 38 0.5× 9 651
Michael Kammüller Switzerland 20 453 1.5× 88 0.3× 73 0.2× 108 0.4× 124 1.5× 43 772
Henrike L. Schieferdecker Germany 18 524 1.7× 50 0.2× 98 0.3× 165 0.6× 65 0.8× 27 847
Seiko Kato Japan 14 142 0.5× 420 1.4× 127 0.4× 99 0.4× 46 0.6× 80 691

Countries citing papers authored by B Meyer

Since Specialization
Citations

This map shows the geographic impact of B Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Meyer more than expected).

Fields of papers citing papers by B Meyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Meyer. The network helps show where B Meyer may publish in the future.

Co-authorship network of co-authors of B Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of B Meyer. A scholar is included among the top collaborators of B Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Meyer. B Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramakers, Christian, et al.. (2019). Switching from serum to plasma: Implementation of BD Vacutainer® Barricor™ Plasma Blood Collection Tubes improves sample quality and laboratory turnaround time. Practical Laboratory Medicine. 18. e00149–e00149. 7 indexed citations
2.
3.
Henry, Jake Y., Marie‐Christine Labarthe, B Meyer, et al.. (2013). Enhanced cross‐priming of naive CD8+T cells by dendritic cells treated by the IMiDs® immunomodulatory compounds lenalidomide and pomalidomide. Immunology. 139(3). 377–385. 75 indexed citations
4.
Leitner, Judith, B Meyer, Valentin Fuhrmann, et al.. (2011). Multiple-dose pharmacokinetics of anidulafungin during continuous venovenous haemofiltration. Journal of Antimicrobial Chemotherapy. 66(4). 880–884. 37 indexed citations
5.
Henry, Jake Y., Ling Lu, Mary Adams, et al.. (2011). Lenalidomide enhances the anti‐prostate cancer activity of docetaxel in vitro and in vivo. The Prostate. 72(8). 856–867. 18 indexed citations
6.
Meyer, B, et al.. (2010). T regulatory cells, the evolution of targeted immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1806(1). 7–17. 30 indexed citations
7.
Henry, Jake Y., et al.. (2010). Abstract 5386: Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo. Cancer Research. 70(8_Supplement). 5386–5386. 2 indexed citations
8.
Michael, Agnieszka, Justin C. St. John, B Meyer, & Hardev Pandha. (2010). Activation and Genetic Modification of Human Monocyte-Derived Dendritic Cells using AttenuatedSalmonella typhimurium. The Scientific World JOURNAL. 10. 393–401. 4 indexed citations
9.
Giezendanner, N., et al.. (2009). Rohmilch-assoziierte Staphylococcus aureus Intoxikation bei Kindern. Schweizer Archiv für Tierheilkunde. 151(7). 329–331. 11 indexed citations
10.
Meyer, B, Wai M. Liu, Angus Dalgleish, & Christine Galustian. (2009). The Role of Tregs in Cancer: Foxp3 as a Putative Target for Therapy. Current Signal Transduction Therapy. 4(2). 122–129. 2 indexed citations
11.
Copier, John, B Meyer, Mark Bodman‐Smith, et al.. (2009). T-regulatory cell modulation: the future of cancer immunotherapy?. British Journal of Cancer. 100(11). 1697–1703. 76 indexed citations
12.
Liu, Wai M., Jake Y. Henry, B Meyer, et al.. (2009). Inhibition of metastatic potential in colorectal carcinoma in vivo and in vitro using immunomodulatory drugs (IMiDs). British Journal of Cancer. 101(5). 803–812. 34 indexed citations
13.
Galustian, Christine, B Meyer, Marie‐Christine Labarthe, et al.. (2008). The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells. Cancer Immunology Immunotherapy. 58(7). 1033–1045. 324 indexed citations
14.
Stummvoll, Georg, Ruth Fritsch‐Stork, B Meyer, et al.. (2008). Characterisation of cellular and humoral autoimmune responses to histone H1 and core histones in human systemic lupus erythaematosus. Annals of the Rheumatic Diseases. 68(1). 110–116. 22 indexed citations
15.
Meyer, B, et al.. (2006). Persistently high levels of immunosuppressive cytokines in patients after radical prostatectomy. Prostate Cancer and Prostatic Diseases. 9(4). 420–425. 6 indexed citations
16.
Pandha, Hardev, et al.. (2006). Antitumor Effects of Aminobisphosphonates on Renal Cell Carcinoma Cell Lines. The Journal of Urology. 176(5). 2255–2261. 21 indexed citations
17.
Meyer, B, Annemarie Unger, Mariam Nikfardjam, et al.. (2006). Critical illness polyneuropathy: incidence and risk factors. Critical Care. 10(Suppl 1). P461–P461. 2 indexed citations
18.
Meyer, B, et al.. (2005). Pro-B-type natriuretic peptide predicts mortality in critically ill patients. Critical Care. 9(Suppl 1). P329–P329.
19.
Meyer, B, Deddo Moertl, M Huelsmann, Richard Pacher, & Rudolf Berger. (2005). In the long term heart transplantation provides additional benefit in transplant candidates with uptitrated ACE-inhibitor- and β-blocker-therapy. The Journal of Heart and Lung Transplantation. 24(2). S69–S69. 3 indexed citations
20.
Meyer, B, Friederike Traunmüller, Ahmad Hamwi, et al.. (2004). Pharmacokinetics of teicoplanin during continuous hemofiltration with a new and a 24-h used highly permeable membrane: rationale for therapeutic drug monitoring-guided dosage. International Journal of Clinical Pharmacology and Therapeutics. 42(10). 556–560. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toru Masaoka Breakdown of academic impact, for papers by S Okamura Breakdown of academic impact, for papers by Issaka Yougbaré Breakdown of academic impact, for papers by Masanori Higuchi Breakdown of academic impact, for papers by Mayuko Tamura Breakdown of academic impact, for papers by Marie‐Lorraine Chrétien Breakdown of academic impact, for papers by Diana Chan Breakdown of academic impact, for papers by Michael Kammüller Breakdown of academic impact, for papers by Henrike L. Schieferdecker Breakdown of academic impact, for papers by Seiko Kato
Rankless by CCL
2026